Bio-Techne Corporation (TECH) announced that its shareholders have voted to approve the definitive merger agreement for its acquisition by Merck KGaA, Darmstadt, Germany. The approval was granted during a special meeting of shareholders held on September 23, 2026.

Key Details

  • Event: Approval of the Merger Agreement Proposal at a special shareholder meeting.
  • Acquirer: Merck KGaA, Darmstadt, Germany.
  • Voting Results: The proposal was approved with 121,929,544 votes for, 1,208,817 against, and 30,610 abstaining.
  • Expected Closing: The transaction is anticipated to close by late 2026 or early 2027, subject to remaining regulatory approvals and customary closing conditions.